← Leaderboards
Alyssa Ione Clay-Gilmour
Roswell Park Cancer Institute Corp
$1,711,362
Attributed
$5,805,349
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,805,349 · 2
By mechanism
R01$3,120,296 · 1
U01$2,685,053 · 1
Top collaborators
- Theresa E Hahn5 shared
- Henrik Hjalgrim5 shared
- James Dowling Mckay5 shared
- Sophia S. Wang5 shared
- Qianqian Zhu5 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Theresa E Hahn$4,613,853
- Qiang Li$1,428,645
- Qianqian Zhu$1,921,800
- Mukund Seshadri$11,493,912
- Kathryn L Lunetta$12,857,453
Others in their field
Other Emerging Leaders on “Etiology”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$35,120,637
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$21,969,486
- Emmanuel Aja Oga · Research Triangle Institute$16,110,065
- Vanessa Rivera-Amill · Ponce School Of Medicine$12,587,042
- Julie Stoner · University Of Oklahoma Hlth Sciences Ctr$12,318,552
- Alberto Rafael Ramos · University Of Miami School Of Medicine$11,170,423
Research focus
EtiologyGeneticVariantValidationPolygenic Risk ScoreGenetic StudyGenotypeGenome Wide Association StudyPredispositionUnited States National Institutes Of HealthResourcesClinical PracticeCollaborationsGenetic VariantEuropeanBiobankBindingAmericanB Cell ProliferationBayesian MethodAllogenicAffectCodeAutoimmune Diseases
Grant awards (10)
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation$605,569
R01 · FY2025 · CA
InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies.$544,532
U01 · FY2025 · CA
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation$593,753
R01 · FY2024 · CA
InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies.$510,942
U01 · FY2024 · CA
InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies.$529,273
U01 · FY2023 · CA
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation$503,068
R01 · FY2023 · CA
InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies.$529,422
U01 · FY2022 · CA
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation$463,641
R01 · FY2022 · CA
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation$954,265
R01 · FY2021 · CA
InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies.$570,884
U01 · FY2021 · CA